Global Anticoagulant Reversal Drugs Databank Market Report

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,000	100 Pages	Magna Intelligence	April, 2024	MAIN18740201

Best Price Guarantee
Price	from $2,000
Length	100 Pages
Publisher	Magna Intelligence
Published Date	April, 2024
SKU	MAIN18740201

Global Anticoagulant Reversal Drugs Databank Market Report

The Anticoagulant Reversal Drugs market was valued at $751.6 Million in 2022, and is projected to reach $2,176.4 Million by 2031 growing at a CAGR of 12.61% from 2023 to 2031. Idarucizumab segment is expected to be the highest contributor to this market, with $288.6 Million in 2022, and is anticipated to reach $799.0 Million by 2031, registering a CAGR of 12.05%. Phytonadione segment is anticipated to reach $189.8 Million by 2031 with the highest CAGR of 15.75%. Idarucizumab and Andexanet Alfa segments collectively expected to account for about 64.9% share of the Anticoagulant Reversal Drugs market in 2022, with the former constituting around 38.4% share. Phytonadione and Protamine segments are expected to witness significant growth rates at a CAGR of 15.75% and 15.51% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 9.5% in the overall Anticoagulant Reversal Drugs market in 2022, and is anticipated to reach 12.2% by 2031.

1. Global Anticoagulant Reversal Drugs Market, By Product Type: 1.1. Overview; 1.2. Prothrombin Complex Concentrates; 1.2.1 Prothrombin Complex Concentrates Market, By Region; 1.2.1.1 North America Prothrombin Complex Concentrates Market, By Country; 1.2.1.2 Europe Prothrombin Complex Concentrates Market, By Country; 1.2.1.3 Asia-Pacific Prothrombin Complex Concentrates Market, By Country; 1.2.1.4 Rest of World Prothrombin Complex Concentrates Market, By Country; 1.3. Phytonadione; 1.3.1 Phytonadione Market, By Region; 1.3.1.1 North America Phytonadione Market, By Country; 1.3.1.2 Europe Phytonadione Market, By Country; 1.3.1.3 Asia-Pacific Phytonadione Market, By Country; 1.3.1.4 Rest of World Phytonadione Market, By Country; 1.4. Andexanet Alfa; 1.4.1 Andexanet Alfa Market, By Region; 1.4.1.1 North America Andexanet Alfa Market, By Country; 1.4.1.2 Europe Andexanet Alfa Market, By Country; 1.4.1.3 Asia-Pacific Andexanet Alfa Market, By Country; 1.4.1.4 Rest of World Andexanet Alfa Market, By Country; 1.5. Idarucizumab; 1.5.1 Idarucizumab Market, By Region; 1.5.1.1 North America Idarucizumab Market, By Country; 1.5.1.2 Europe Idarucizumab Market, By Country; 1.5.1.3 Asia-Pacific Idarucizumab Market, By Country; 1.5.1.4 Rest of World Idarucizumab Market, By Country; 1.6. Protamine; 1.6.1 Protamine Market, By Region; 1.6.1.1 North America Protamine Market, By Country; 1.6.1.2 Europe Protamine Market, By Country; 1.6.1.3 Asia-Pacific Protamine Market, By Country; 1.6.1.4 Rest of World Protamine Market, By Country; 1.7. Other Product Types; 1.7.1 Other Product Types Market, By Region; 1.7.1.1 North America Other Product Types Market, By Country; 1.7.1.2 Europe Other Product Types Market, By Country; 1.7.1.3 Asia-Pacific Other Product Types Market, By Country; 1.7.1.4 Rest of World Other Product Types Market, By Country
2. Global Anticoagulant Reversal Drugs Market, By Distribution Channel: 2.1. Overview; 2.2. Hospital Pharmacy; 2.2.1 Hospital Pharmacy Market, By Region; 2.2.1.1 North America Hospital Pharmacy Market, By Country; 2.2.1.2 Europe Hospital Pharmacy Market, By Country; 2.2.1.3 Asia-Pacific Hospital Pharmacy Market, By Country; 2.2.1.4 Rest of World Hospital Pharmacy Market, By Country; 2.3. Retail Pharmacy; 2.3.1 Retail Pharmacy Market, By Region; 2.3.1.1 North America Retail Pharmacy Market, By Country; 2.3.1.2 Europe Retail Pharmacy Market, By Country; 2.3.1.3 Asia-Pacific Retail Pharmacy Market, By Country; 2.3.1.4 Rest of World Retail Pharmacy Market, By Country; 2.4. Online Pharmacy; 2.4.1 Online Pharmacy Market, By Region; 2.4.1.1 North America Online Pharmacy Market, By Country; 2.4.1.2 Europe Online Pharmacy Market, By Country; 2.4.1.3 Asia-Pacific Online Pharmacy Market, By Country; 2.4.1.4 Rest of World Online Pharmacy Market, By Country
3. Global Anticoagulant Reversal Drugs Market, By Region: 3.1. Overview; 3.2. North America; 3.2.1 North America Anticoagulant Reversal Drugs Market, By Product Type; 3.2.2 North America Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.2.3 North America Anticoagulant Reversal Drugs Market, By Country; 3.2.3.1 U.S.; 3.2.3.1.1 U.S. Anticoagulant Reversal Drugs Market, By Product Type; 3.2.3.1.2 U.S. Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.2.3.2 Canada; 3.2.3.2.1 Canada Anticoagulant Reversal Drugs Market, By Product Type; 3.2.3.2.2 Canada Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.3. Europe; 3.3.1 Europe Anticoagulant Reversal Drugs Market, By Product Type; 3.3.2 Europe Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.3.3 Europe Anticoagulant Reversal Drugs Market, By Country; 3.3.3.1 Germany; 3.3.3.1.1 Germany Anticoagulant Reversal Drugs Market, By Product Type; 3.3.3.1.2 Germany Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.3.3.2 U.K.; 3.3.3.2.1 U.K. Anticoagulant Reversal Drugs Market, By Product Type; 3.3.3.2.2 U.K. Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.3.3.3 France; 3.3.3.3.1 France Anticoagulant Reversal Drugs Market, By Product Type; 3.3.3.3.2 France Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.3.3.4 Italy; 3.3.3.4.1 Italy Anticoagulant Reversal Drugs Market, By Product Type; 3.3.3.4.2 Italy Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.3.3.5 Spain; 3.3.3.5.1 Spain Anticoagulant Reversal Drugs Market, By Product Type; 3.3.3.5.2 Spain Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.3.3.6 Rest of Europe; 3.3.3.6.1 Rest of Europe Anticoagulant Reversal Drugs Market, By Product Type; 3.3.3.6.2 Rest of Europe Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.4. Asia-Pacific; 3.4.1 Asia-Pacific Anticoagulant Reversal Drugs Market, By Product Type; 3.4.2 Asia-Pacific Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.4.3 Asia-Pacific Anticoagulant Reversal Drugs Market, By Country; 3.4.3.1 China; 3.4.3.1.1 China Anticoagulant Reversal Drugs Market, By Product Type; 3.4.3.1.2 China Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.4.3.2 Japan; 3.4.3.2.1 Japan Anticoagulant Reversal Drugs Market, By Product Type; 3.4.3.2.2 Japan Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.4.3.3 South Korea; 3.4.3.3.1 South Korea Anticoagulant Reversal Drugs Market, By Product Type; 3.4.3.3.2 South Korea Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.4.3.4 India; 3.4.3.4.1 India Anticoagulant Reversal Drugs Market, By Product Type; 3.4.3.4.2 India Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.4.3.5 Singapore; 3.4.3.5.1 Singapore Anticoagulant Reversal Drugs Market, By Product Type; 3.4.3.5.2 Singapore Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.4.3.6 Rest of Asia; 3.4.3.6.1 Rest of Asia Anticoagulant Reversal Drugs Market, By Product Type; 3.4.3.6.2 Rest of Asia Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.5. Rest of World; 3.5.1 Rest of World Anticoagulant Reversal Drugs Market, By Product Type; 3.5.2 Rest of World Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.5.3 Rest of World Anticoagulant Reversal Drugs Market, By Country; 3.5.3.1 Brazil; 3.5.3.1.1 Brazil Anticoagulant Reversal Drugs Market, By Product Type; 3.5.3.1.2 Brazil Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.5.3.2 Mexico; 3.5.3.2.1 Mexico Anticoagulant Reversal Drugs Market, By Product Type; 3.5.3.2.2 Mexico Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.5.3.3 South Africa; 3.5.3.3.1 South Africa Anticoagulant Reversal Drugs Market, By Product Type; 3.5.3.3.2 South Africa Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.5.3.4 Australia; 3.5.3.4.1 Australia Anticoagulant Reversal Drugs Market, By Product Type; 3.5.3.4.2 Australia Anticoagulant Reversal Drugs Market, By Distribution Channel; 3.5.3.5 ROW Countries; 3.5.3.5.1 ROW Countries Anticoagulant Reversal Drugs Market, By Product Type; 3.5.3.5.2 ROW Countries Anticoagulant Reversal Drugs Market, By Distribution Channel; ROW Countries Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD LIST OF TABLES; TABLE 1. Global Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 2. Prothrombin Complex Concentrates Market Value, By Region, 2022-2031, Million USD; TABLE 3. North America Prothrombin Complex Concentrates Market Value, By Country, 2022-2031, Million USD; TABLE 4. Europe Prothrombin Complex Concentrates Market Value, By Country, 2022-2031, Million USD; TABLE 5. Asia-Pacific Prothrombin Complex Concentrates Market Value, By Country, 2022-2031, Million USD; TABLE 6. Rest of World Prothrombin Complex Concentrates Market Value, By Country, 2022-2031, Million USD; TABLE 7. Phytonadione Market Value, By Region, 2022-2031, Million USD; TABLE 8. North America Phytonadione Market Value, By Country, 2022-2031, Million USD; TABLE 9. Europe Phytonadione Market Value, By Country, 2022-2031, Million USD; TABLE 10. Asia-Pacific Phytonadione Market Value, By Country, 2022-2031, Million USD; TABLE 11. Rest of World Phytonadione Market Value, By Country, 2022-2031, Million USD; TABLE 12. Andexanet Alfa Market Value, By Region, 2022-2031, Million USD; TABLE 13. North America Andexanet Alfa Market Value, By Country, 2022-2031, Million USD; TABLE 14. Europe Andexanet Alfa Market Value, By Country, 2022-2031, Million USD; TABLE 15. Asia-Pacific Andexanet Alfa Market Value, By Country, 2022-2031, Million USD; TABLE 16. Rest of World Andexanet Alfa Market Value, By Country, 2022-2031, Million USD; TABLE 17. Idarucizumab Market Value, By Region, 2022-2031, Million USD; TABLE 18. North America Idarucizumab Market Value, By Country, 2022-2031, Million USD; TABLE 19. Europe Idarucizumab Market Value, By Country, 2022-2031, Million USD; TABLE 20. Asia-Pacific Idarucizumab Market Value, By Country, 2022-2031, Million USD; TABLE 21. Rest of World Idarucizumab Market Value, By Country, 2022-2031, Million USD; TABLE 22. Protamine Market Value, By Region, 2022-2031, Million USD; TABLE 23. North America Protamine Market Value, By Country, 2022-2031, Million USD; TABLE 24. Europe Protamine Market Value, By Country, 2022-2031, Million USD; TABLE 25. Asia-Pacific Protamine Market Value, By Country, 2022-2031, Million USD; TABLE 26. Rest of World Protamine Market Value, By Country, 2022-2031, Million USD; TABLE 27. Other Product Types Market Value, By Region, 2022-2031, Million USD; TABLE 28. North America Other Product Types Market Value, By Country, 2022-2031, Million USD; TABLE 29. Europe Other Product Types Market Value, By Country, 2022-2031, Million USD; TABLE 30. Asia-Pacific Other Product Types Market Value, By Country, 2022-2031, Million USD; TABLE 31. Rest of World Other Product Types Market Value, By Country, 2022-2031, Million USD; TABLE 32. Global Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 33. Hospital Pharmacy Market Value, By Region, 2022-2031, Million USD; TABLE 34. North America Hospital Pharmacy Market Value, By Country, 2022-2031, Million USD; TABLE 35. Europe Hospital Pharmacy Market Value, By Country, 2022-2031, Million USD; TABLE 36. Asia-Pacific Hospital Pharmacy Market Value, By Country, 2022-2031, Million USD; TABLE 37. Rest of World Hospital Pharmacy Market Value, By Country, 2022-2031, Million USD; TABLE 38. Retail Pharmacy Market Value, By Region, 2022-2031, Million USD; TABLE 39. North America Retail Pharmacy Market Value, By Country, 2022-2031, Million USD; TABLE 40. Europe Retail Pharmacy Market Value, By Country, 2022-2031, Million USD; TABLE 41. Asia-Pacific Retail Pharmacy Market Value, By Country, 2022-2031, Million USD; TABLE 42. Rest of World Retail Pharmacy Market Value, By Country, 2022-2031, Million USD; TABLE 43. Online Pharmacy Market Value, By Region, 2022-2031, Million USD; TABLE 44. North America Online Pharmacy Market Value, By Country, 2022-2031, Million USD; TABLE 45. Europe Online Pharmacy Market Value, By Country, 2022-2031, Million USD; TABLE 46. Asia-Pacific Online Pharmacy Market Value, By Country, 2022-2031, Million USD; TABLE 47. Rest of World Online Pharmacy Market Value, By Country, 2022-2031, Million USD; TABLE 48. Global Anticoagulant Reversal Drugs Market Value, By Region, 2022-2031, Million USD; TABLE 49. North America Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 50. North America Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 51. North America Anticoagulant Reversal Drugs Market Value, By Country, 2022-2031, Million USD; TABLE 52. U.S. Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 53. U.S. Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 54. Canada Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 55. Canada Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 56. Europe Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 57. Europe Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 58. Europe Anticoagulant Reversal Drugs Market Value, By Country, 2022-2031, Million USD; TABLE 59. Germany Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 60. Germany Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 61. U.K. Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 62. U.K. Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 63. France Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 64. France Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 65. Italy Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 66. Italy Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 67. Spain Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 68. Spain Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 69. Rest of Europe Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 70. Rest of Europe Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 71. Asia-Pacific Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 72. Asia-Pacific Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 73. Asia-Pacific Anticoagulant Reversal Drugs Market Value, By Country, 2022-2031, Million USD; TABLE 74. China Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 75. China Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 76. Japan Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 77. Japan Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 78. South Korea Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 79. South Korea Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 80. India Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 81. India Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 82. Singapore Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 83. Singapore Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 84. Rest of Asia Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 85. Rest of Asia Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 86. Rest of World Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 87. Rest of World Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 88. Rest of World Anticoagulant Reversal Drugs Market Value, By Country, 2022-2031, Million USD; TABLE 89. Brazil Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 90. Brazil Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 91. Mexico Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 92. Mexico Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 93. South Africa Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 94. South Africa Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 95. Australia Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 96. Australia Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; TABLE 97. ROW Countries Anticoagulant Reversal Drugs Market Value, By Product Type, 2022-2031, Million USD; TABLE 98. ROW Countries Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD; ROW Countries Anticoagulant Reversal Drugs Market Value, By Distribution Channel, 2022-2031, Million USD